Illumina, Inc.
5200 Illumina Way
San Diego, CA 92122
February 5, 2021
Via EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549-3561
Attn: Courtney Lindsay
| Re: |
Illumina, Inc. Registration Statement on Form S-4 Filed November 25, 2020 File No. 333-250941 |
Ladies and Gentleman:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Illumina, Inc., a Delaware corporation (the “Company”), hereby requests that the effective date of the above-referenced registration statement on Form S-4 (the “Registration Statement”) be accelerated so that the Registration Statement may become effective at 4 p.m. Eastern Time on February 9, 2021, or as soon as practicable thereafter.
Once the Registration Statement is declared effective, please orally confirm the event with our counsel, Covington & Burling LLP, by calling David H. Engvall at (202) 662-5307, and then send written confirmation to the addressees listed on the cover of the Registration Statement.
Thank you for your assistance in this matter.
| Very truly yours, | ||
| Illumina, Inc. | ||
| By: |
/s/ CHARLES E. DADSWELL | |
| Name: Charles E. Dadswell | ||
| Title: Senior Vice President, General Counsel and Secretary | ||
cc: David H. Engvall, Covington & Burling LLP